We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Coke can leverage strong bottler relationships in underpenetrated emerging markets to drive volume growth with classic recipes as well as new products tailored to local tastes. Secular headwinds ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

With the latest fund flow data, you can shine a light on trends and forecasts across asset classes. Grade investments with a scorecard or create peer groups to compare products head-to-head.

From data feeds to comprehensive platforms, Morningstar Data helps asset and wealth managers build their assets by supporting market research, product positioning, marketing, and distribution ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

In the second quarter for 2024, the global universe of sustainable open-ended and exchange-traded funds attracted an estimated USD 4.3 billion of net new money, compared with restated outflows of ...

New public and private entrants are emerging to challenge the leading positions of Novo Nordisk NVO and Eli Lilly LLY in a ...

That was one of the pieces of feedback from my recent article about short- and intermediate-term portfolios, which mainly ...